Effects of Astaxanthin on Hepatic Steatosis in Animal Models of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Abstract
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of chronic liver disorders
characterized by excessive lipid accumulation in hepatocytes in the absence of significant alcohol
consumption. It has emerged as one of the leading causes of chronic liver disease worldwide,
closely associated with metabolic syndrome, obesity, insulin resistance, and type 2 diabetes
mellitus. The disease spectrum ranges from simple steatosis, which is often considered relatively
benign, to non-alcoholic steatohepatitis (NASH), a more aggressive form characterized by
hepatocellular injury, inflammation, and varying degrees of fibrosis that may ultimately progress
to cirrhosis and hepatocellular carcinoma.
Downloads
Download data is not yet available.
Downloads
Published
2026-04-11
Issue
Section
Articles